(CLS) Celestica - Ratings and Ratios
Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA15101Q2071
CLS: Manufacturing, Engineering, Design, Logistics,
Celestica Inc. (NYSE:CLS) is a global leader in supply chain solutions, operating across North America, Europe, and Asia. The company is divided into two main segments: Advanced Technology Solutions and Connectivity and Cloud Solutions. It specializes in end-to-end product manufacturing and supply chain services, including design and development, new product introduction, engineering, component sourcing, electronics manufacturing, assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair services. Additionally, Celestica offers hardware platform solutions, such as infrastructure development, hardware and software design, and open-source software customization. The company also manages programs encompassing design, supply chain, manufacturing, and after-market support, including IT asset disposition and asset management. Its customer base includes original equipment manufacturers, cloud-based and hyperscale service providers, aerospace and defense firms, industrial companies, HealthTech organizations, capital equipment manufacturers, communications providers, and enterprise markets. Celestica was founded in 1994 and is headquartered in Toronto, Canada.
Based on the provided data, Celesticas stock is expected to show moderate volatility over the next three months. The SMA 20 and SMA 50 indicate a potential downtrend, with the stock price currently at $88.19, above the SMA 20 ($79.34) but below the SMA 50 ($93.90). The ATR of 7.30 suggests moderate price fluctuations. Fundamentally, the companys P/E ratio of 22.32 and forward P/E of 17.45 indicate a premium valuation, while the P/B ratio of 5.14 reflects strong book value. The RoE of 22.57 highlights efficient profitability. With a market cap of $9.345 billion and a P/S ratio of 0.97, Celestica is well-positioned in its industry, but investors should monitor the stocks movement relative to its SMA levels and broader market conditions.
Additional Sources for CLS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CLS Stock Overview
Market Cap in USD | 10,258m |
Sector | Technology |
Industry | Electronic Components |
GiC Sub-Industry | Electronic Manufacturing Services |
IPO / Inception | 1998-06-30 |
CLS Stock Ratings
Growth Rating | 89.3 |
Fundamental | 52.2 |
Dividend Rating | 0.0 |
Rel. Strength | 76.5 |
Analysts | 4.27/5 |
Fair Price Momentum | 131.12 USD |
Fair Price DCF | 18.82 USD |
CLS Dividends
No Dividends PaidCLS Growth Ratios
Growth Correlation 3m | -54.9% |
Growth Correlation 12m | 74.4% |
Growth Correlation 5y | 96.4% |
CAGR 5y | 76.19% |
CAGR/Max DD 5y | 1.41 |
Sharpe Ratio 12m | 1.46 |
Alpha | 72.27 |
Beta | 2.918 |
Volatility | 73.15% |
Current Volume | 2955k |
Average Volume 20d | 4130.8k |
As of May 09, 2025, the stock is trading at USD 96.33 with a total of 2,954,996 shares traded.
Over the past week, the price has changed by +7.98%, over one month by +39.91%, over three months by -26.03% and over the past year by +95.28%.
Partly, yes. Based on ValueRay Fundamental Analyses, Celestica (NYSE:CLS) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 52.17 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLS as of May 2025 is 131.12. This means that CLS is currently undervalued and has a potential upside of +36.12% (Margin of Safety).
Celestica has received a consensus analysts rating of 4.27. Therefor, it is recommend to buy CLS.
- Strong Buy: 5
- Buy: 4
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CLS Celestica will be worth about 157.4 in May 2026. The stock is currently trading at 96.33. This means that the stock has a potential upside of +63.34%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 119.7 | 24.2% |
Analysts Target Price | 87.9 | -8.8% |
ValueRay Target Price | 157.4 | 63.3% |